Targeted inhibition of glutaminase as a potential new approach for the treatment of <i>NF1</i> associated soft tissue malignancies
Tahir Sheikh(Herbert Irving Comprehensive Cancer Center), Gary K. Schwartz(Baylor University Medical Center)
Cited by 30
Related Papers
Cetuximab Shows Activity in Colorectal Cancer Patients With Tumors That Do Not Express the Epidermal Growth Factor Receptor by Immunohistochemistry
|Journal of Clinical Oncology|2005|1.1k
Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy
|Nature Genetics|2010|725
Phase II Study of Sorafenib in Patients With Metastatic or Recurrent Sarcomas
|Journal of Clinical Oncology|2009|573